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Purpose/Objective: We have investigated the impact of an 
implanted metal prosthesis on dose distributions in VMAT by 
using a QA water phantom including a metal cylinder. 
Materials and Methods: In order to evaluate the influence of 
the implanted metal prosthesis, we placed a 30 mm thick 
brass cylinder in the QA water phantom. Two plans were 
created: 1) VMAT with split arc segments thereby avoiding 
direct beam deliveries to the prosthesis and femur 
(hereinafter referred to as avoidance VMAT ), and 2) a single 
arc VMAT. We measured the isocenter dose by a Farmer-type 
ion detector and an axial dose distribution using radiochromic 
films with/without the brass cylinder. 
Results: The isocenter dose difference with or without the 
metal cylinder for each of the avoidance VMAT was negligibly 
small. However, a significant dose difference was observed 
for a normal single arc VMAT. Meanwhile, the difference of 
the dose distributions with or without the metal for the 
avoidance VMAT was insignificant. It was further observed 
that the avoidance VMAT led to insignificant dose differences 
in high dose areas such as prostate target, whereas the area 
close to the metal showed large dose differences possibly due 




Conclusions: We observed a significant impact of a metal 
object on dose distributions in VMAT when a single full arc 
beam was delivered. However VMAT beams with the 
avoidance angles did not suffer from the metal effect . This 
result encourages us to use a water phantom without a metal 
object for QA of a prostate cancer patient with a hip 
prosthesis. 
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Purpose/Objective: The purpose of this paper is to present 
the differences in the doses received by critical organs 
(bladder, rectum) during radiotherapy of prostate cancer 
limited to the organ, depending on the size of irradiation 
technology and CTV-PTV margin conditioned by an image 
verification method. 
Materials and Methods: The study was conducted on a group 
of 20 patients who were treated with radiotherapy between 
2012 and 2013. For each patient 20 alternative treatment 
plans were prepared. Plans differ from each other by method 
of irradiation and the size of the CTV-PTV margin. These 
were respectively: (i) the irradiation method - 3DCRT (3 
beams, 20 MV); IMRT (5 beams, 20 MV); IMRT (7 beams, 6 
MV); VMAT (2 arcs, 6 MV) and (ii) margins (M) expressed in 
[mm] and calculated for directions LR / CC / AP - M1 (2/3/4); 
M2 (3/4/5); M3 (6/5/6); M4 (7/6/6); M5 (8/7/7). The 
proposed margins are determined by the image verification 
method (Piotrowski et. Al., Technol Cancer Res Treat, 2014) 
and correspond respectively: M1 - daily CBCT verification; M2 
- CBCT verification during the first five fractions and 
verification of 2D-kV for the remaining fractions; M3 - CBCT 
verification during the first five fractions; M4 - 2D-kV 
verification during the first five fractions; M5 - no image 
verification, positioning based on the marks on the skin of 
the patient. Analysis on the average dose in the bladder and 
rectum, depending on the size of irradiation technology and 
CTV-PTV margin was conducted For statistical analysis, 
Friedman ANOVA test was used. Doses are presented in 
percentage and normalized to total dose (74Gy = 100%). The 
analysis was performed at the level of statistical significance 
equal to 0.05. 
Results: For both bladder and rectum average doses obtained 
for 3DCRT were significantly different from the dose for 
dynamic techniques (IMRT, VMAT) (p<0.01). The average 
difference between the bladder doses for 3DCRT and the 
dynamic techniques was 15%, for rectum difference was 7%. 
No statistically significant differences between the average 
doses for dynamic techniques (p>0.2) were found. Analysis of 
the average doses with respect to used margin showed that 
there were no statistically significant differences between 
the doses obtained for the margins M1 and M2 (p>0.4 for 
bladder and p>0.09 for rectum). Similar observations were 
obtained for doses on M3, M4 and M5 (p> 0.3 for bladder and 
rectum). However, the differences between doses for M1, M2 
and M3, M4 , M5 are statistically significant (p<0.01 for the 
bladder and p<0.03 for the rectum), averaging 10% of the 
bladder and 5% for rectum. 
